La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Basel Medical Group a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Basel Medical Group..

Basel Medical Group (NASDAQ:BMGL) Azioni, Catena delle Opzioni

Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.

Basel Medical Group Ltd - ordinary shares

Basel Medical Group Ltd

Nextdoor Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIND#NYSE">KIND</a>), the essential neighborhood network, announced today that it will be changing its ticker symbol from "KIND" to "NXDR" in connection with the upcoming launch of the company's redesigned product.
Effective July 21, 2025, the company's Class A common stock will trade on the NYSE under the new symbol "NXDR". There is no action required by the company's shareholders with respect to the ticker symbol change. The company's Class A common stock will continue to be listed on the NYSE, and its CUSIP will remain unchanged.
Earnings Conference Call and Webcast Information
Nextdoor will also report second quarter 2025 financial results following the close of the U.S. markets on Thursday, August 7, 2025. Nextdoor will host a video webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET to discuss the results and outlook.

News

KIND

Nextdoor to Change Ticker Symbol to NXDR Ahead of Major Product Relaunch on July 21

Signing Day Sports, Inc. ("Signing Day Sports" or the "Company") (NYSE:<a href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>), the developer of the Signing Day Sports app and platform dedicated to improving the recruiting process for high school athletes and college coaches, today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") by BlockchAIn Digital Infrastructure, Inc., a newly created Delaware corporation ("BlockchAIn").
As previously announced on May 28, 2025, Signing Day Sports entered into a Business Combination Agreement ("BCA") with BlockchAIn, One Blockchain LLC ("One Blockchain"), a developer and operator of digital infrastructure focused on Bitcoin mining and high-performance computing, and certain other parties. The closing of the transactions contemplated by the BCA is subject to certain conditions, including, without limitation, the approval of Signing Day Sports stockholders and approval of the listing of the registered common shares of BlockchAIn by the NYSE American LLC ("NYSE American").

Signing Day Sports Says BlockchAIn Submits Draft Registration Statement On Form S-4 To SEC

Lifezone Metals To File Kabanga Nickel Feasibility Study On July 18; First Reserve Declaration, Webcast Set For July 21









Ask ChatGPT

<a href="https://www.globenewswire.com/Tracker?data=L1UiVV55m4vNSVgRapm_zBV2pruXBpyUmoJdMxFtATHIw9eZaQceP6NQgHHiWemT3Bv8GTzE93FbYxPZ-IS_Un7SRwluUBQbmEi_tcjB76k=">Capricor Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for Deramiocel, the Company's lead cell therapy candidate for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD).
In the CRL, the FDA stated that it had completed its review of the application but is unable to approve the BLA in its current form, specifically citing that the BLA does not meet the statutory requirement for substantial evidence of effectiveness and the need for additional clinical data. The CRL also referenced certain outstanding items in the Chemistry, Manufacturing, and Controls (CMC) section of the application, most of which Capricor believes it has addressed in prior communications to the FDA. However, these materials were not reviewed by the FDA due to the timing of the CRL issuance. The FDA confirmed that it will restart the review clock upon resubmission. In addition, the agency offered the company the opportunity to request a Type A meeting to discuss the path forward. Capricor plans to engage further with the FDA to determine the appropriate next steps.
Capricor's BLA for Deramiocel was granted Priority Review in March 2025 and was supported by data from the HOPE-2 trial, its open-label extension (OLE), and natural history comparisons from FDA-funded datasets.

Government

Regulations

CAPR

Capricor Stock in Focus After FDA Rejects DMD Therapy Application, Citing Need for More Data

GPRO

GoPro Wins Initial ITC Ruling Against Insta360 For HERO Design, HyperSmooth Patent Infringement; Final Decision Due November 10

Rumors

PFGC

USFD

Bloomberg Reported Performance Food Is Said To Draw Takeover Interest From US Foods

The latest attacks by Yemen's Houthi rebels in the Red Sea have triggered a sharp rise in shipping insurance costs, underscoring growing risks to global trade through this critical maritime route.
What Happened: The insurance expenses for shipping goods via the Red Sea have more than doubled following the Houthi attacks, which resulted in the sinking of two ships and the loss of at least four sailors, Reuters reported on Thursday.
The attacks occurred after a period of relative calm, causing a sharp decline in Red Sea traffic.
The war risk premiums have surged to approximately 0.7% of a ship&#8217;s value, up from about 0.3% before the recent attacks. Some insurers have temporarily suspended coverage for specific voyages, while rates for a standard seven-day journey have climbed to as high as 1% this week, matching the peak levels seen in 2024 during a period of frequent daily attacks.
Neil Roberts, head of marine and aviation at the Lloyd's Market Association, stressed the importance of exercising caution when planning transits through the Red Sea in light of the recent attacks.
See Also: <a href="https://benzinga.com/news/politics/25/07/46360429/mike-pence-says-trumps-tariff-escalations-with-us-allies-are-like-dismissing-your-front-line-in-a-f" target="_blank" rel="noopener">Mike Pence Says Trump&#8217;s Tariff Escalations With US Allies Are Like &#8216;Dismissing Your Front Line In A Football Game&#8217;</a>
Why It Matters: A Houthi assault on the Greek vessel Eternity C on Wednesday resulted in the deaths of four out of 25 crew members, according to maritime officials.
On Thursday, rescuers recovered four additional survivors from the Red Sea, while Houthi militants claimed to be holding some missing crew members. The incident came just days after another Greek-operated ship was sunk on Monday, an attack for which the Houthis also took responsibility.
Shipping data analysis indicates that some of these vessels had visited Israeli ports within the past year. Between November 2023 and December 2024, the Houthis carried out attacks on more than 100 ships.
In September 2024, the <a href="https://www.benzinga.com/news/24/09/40680857/us-military-slams-houthis-reckless-acts-of-terrorism-after-yemen-rebels-strike-2-oil">U.S. military condemned</a> the Houthi attacks on two crude oil tankers in the Red Sea as &#8220;reckless acts of terrorism.&#8221; This incident, along with the ongoing conflict with the Houthi rebels, was described by a top U.S. Navy admiral as the <a href="https://www.benzinga.com/news/24/02/37213385/top-us-navy-admiral-declares-red-sea-conflict-the-largest-naval-battle-since-wwii-with-7-000-sailors">largest naval battle</a> the U.S. has faced since World War II.
Moreover, Iran, which is aligned with the Houthi rebels, has been <a href="https://www.benzinga.com/markets/eurozone/25/06/46113873/iran-loses-influence-in-opec-after-years-of-sanctions-regional-meddling">losing influence in OPEC</a> due to years of sanctions and its meddling in the Middle East.
Read Next:
<ul class="wp-block-list">
<li><a href="https://benzinga.com/markets/macro-economic-events/25/07/46336626/trump-administration-sues-gavin-newsom-other-state-officials-over-californias-egg-l" target="_blank" rel="noopener">Trump Administration Sues Gavin Newsom, Other State Officials Over California&#8217;s Egg Laws Driving Up Prices Nationwide: &#8216;Unnecessary Red Tape&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Red Sea Shipping Insurance Costs Surge After Deadly Houthi Strikes: Report

Michael Dell, the CEO of&nbsp;Dell Technologies Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), expressed concerns about the potential cultural challenges that&nbsp;Meta Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) might face due to its aggressive artificial intelligence hiring strategy.
What Happened: Dell, in a&nbsp;BG2 podcast hosted by Bill Gurley and Brad Gerstner, on Thursday, warned that Meta&#8217;s AI hiring spree could lead to internal discontent among existing employees. This could result in a significant distraction for Meta and its CEO,&nbsp;Mark Zuckerberg.
Check out the current price of&nbsp;<a href="https://benzinga.com/quote/META" target="_blank" rel="noreferrer noopener">META stock here</a>.
&#8220;It&#8217;ll&nbsp;be a challenge culturally for&nbsp;sure,&#8221; Dell said. He pointed out that the generous salaries of new AI hires could lead to unhappiness and resentment among existing employees. This could potentially create a long line of &#8220;complaining&#8221; employees outside Zuckerberg&#8217;s office, demanding fair treatment.
Dell emphasized the importance of fairness in the workplace, stating, &#8220;People&nbsp;generally have a sense of&nbsp;fairness, right? They&nbsp;want to be treated fairly&nbsp;relative to others and relative&nbsp;to&nbsp;the opportunities that they have&nbsp;out there in the overall&nbsp;market.&#8221;
While Dell acknowledged that Meta&#8217;s strategy and the &#8220;math&#8221; could work if this is reduced to a &#8220;race to super intelligence,&#8221; he maintained that the potential for internal conflict and dissatisfaction should not be overlooked.
See Also&nbsp;<a href="https://benzinga.com/news/politics/25/07/46268640/china-expresses-concern-to-eu-over-russias-potential-defeat-in-ukraine-conflict-amid-fears-that-trump-would-do-this-report" target="_blank" rel="noreferrer noopener">China Expresses Concern To EU Over Russia&#8217;s Potential Defeat In Ukraine Conflict Amid Fears That Trump Would Do &#8216;This&#8217;: Report</a>
Why It Matters: Meta has been aggressively expanding its AI dominance through its Superintelligence Labs, launched in June to pursue artificial general intelligence. This expansion has been fueled by <a href="https://www.benzinga.com/markets/tech/25/07/46301582/metas-ai-empire-grows-fueled-by-openai-deepmind-apple-defectors">poaching top talent</a> from OpenAI, Anthropic, Alphabet Inc.‘s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google DeepMind, and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), reshaping the AI landscape in a fierce talent war. 
However, this aggressive hiring spree has not been without criticism. Like Dell, OpenAI CEO Sam Altman previously warned of potential <a href="https://www.benzinga.com/markets/tech/25/07/46216611/openais-sam-altman-hints-at-compensation-evaluation-amid-metas-distasteful-ai-talent-poaching-spree-report">cultural problems</a> at Meta due to its recruitment efforts, calling it "distasteful". He also hinted at possible compensation evaluations for the entire research organization at OpenAI in response to Meta&#8217;s hiring strategy.&nbsp;
On the other hand, Reid Hoffman, LinkedIn cofounder and former OpenAI board member, <a href="https://www.cnbc.com/video/2025/07/09/watch-cnbcs-full-interview-with-linkedin-co-founder-reid-hoffman-in-sun-valley.html">told </a>CNBC it&#8217;s economically justified for companies like Meta to invest heavily in AI talent.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Michael Dell – Invest America Act Becomes Law, AI Talent Wars, Compute Demand, Market Update &#x7C; BG2" width="500" height="281" src="https://www.youtube.com/embed/X52BNWZrXSk?start=2541&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46337678/chamath-palihapitiya-agrees-with-a-social-media-user-who-says-while-meta-spends-200-million-a-year-to-poach-ai-talent-elon-musk-keeps-costs-low-but-still-manages-to-unveil-better-products">Chamath Palihapitiya Agrees With A Social Media User Who Says While Meta Spends $200 Million A Year To Poach AI Talent, Elon Musk Keeps Costs Low But Still Manages To Unveil Better Products</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

AAPL

DELL

GOOG

GOOGL

Mark Zuckerberg May Have To Deal With A Long Line Of 'Complaining' Employees Outside Of His Door, Warns Michael Dell, Calls Meta's AI Hiring Spree 'Cultural Challenge'

Panasonic Holdings Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCRFF#OTC">PCRFF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PCRHY#OTC">PCRHY</a>) is delaying its plans to scale up operations at its second plant in the U.S., as customer Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is grappling with sluggish sales figures.
Check out the current price of <a href="https://benzinga.com/quote/tsla">TSLA stock here</a>.
What Happened: The company will delay its plan to reach the full production capacity of 30 Gigawatt-hours by 2027 at its De-Soto, Kansas, plant, Nikkei Asia reported <a href="https://asia.nikkei.com/Business/Electronics/Panasonic-delays-full-production-at-US-battery-plant-as-Tesla-sales-drop">on</a> Friday.
The $4B plant will begin production soon, although a new date has not been decided as of yet, the report suggests. Panasonic set up its first plant in the U.S. in collaboration with Tesla in the state of Nevada, dubbed the Nevada Gigafactory, in 2014.
Why It Matters: Tesla sales have taken a hit in the past year as the company recorded poor sales figures <a href="https://www.benzinga.com/markets/eurozone/25/06/45736798/tesla-sales-hit-3-year-low-in-this-european-nation-despite-musks-claims-of-no-demand-problem">in multiple markets</a>. The company also experienced double-digit drops in sales in <a href="https://www.benzinga.com/markets/tech/25/07/46189042/elon-musk-led-teslas-european-woes-worsen-with-sales-down-over-60-in-sweden-and-denmark">Denmark and Sweden</a>.&nbsp;
The company has also<a href="https://www.benzinga.com/markets/tech/25/07/46337215/tesla-is-basically-hijacked-by-elon-musk-says-ross-gerber-calling-it-completely-ridiculous-america-party-is-the-worst-news-for-tsla"> been under fire</a> for CEO Elon Musk's feud with President Donald Trump over the latter's Big, Beautiful Bill, which Musk says would add trillions to the U.S. debt deficit.
Meanwhile, Tesla investors have expressed concerns with the company's dwindling sales, as over 27 major shareholders urged the Tesla BoD to hold its annual shareholder meeting, which the company says it will hold on <a href="https://www.benzinga.com/markets/tech/25/07/46359669/teslas-annual-shareholder-meeting-set-for-november-6th-dan-ives-says-elon-musks-pay-package-in-the-spotlight">November 6th this year</a>.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="200" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11060315/TSLA-JUL-11-2025-4-1024x200.jpg" alt="" class="wp-image-981576" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11060315/TSLA-JUL-11-2025-4-1024x200.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11060315/TSLA-JUL-11-2025-4-300x59.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11060315/TSLA-JUL-11-2025-4-768x150.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11060315/TSLA-JUL-11-2025-4-1536x300.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/11060315/TSLA-JUL-11-2025-4.jpg 1568w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Tesla offers poor Momentum and Value, while scoring well on the Growth metric and offering satisfactory Quality. For more such insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46360024/trump-nominates-tesla-critic-to-lead-nhtsa-amid-rising-tensions-with-elon-musk">Trump Nominates Tesla Critic To Lead NHTSA Amid Rising Tensions With Elon Musk</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

PCRFF

PCRHY

TSLA

Tesla Sales Slump Prompts Panasonic To Delay $4 Billion US Battery Plant Expansion: Report

HC Wainwright &amp; Co. analyst Andrew Fein reiterates KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) with a Buy and maintains $27 price target.

Price Target

Reiteration

Analyst Ratings

KALV

HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $27 Price Target

HC Wainwright &amp; Co. analyst Robert Burns assumes Karyopharm Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) with a Buy rating and announces Price Target of $27.

Initiation

KPTI

HC Wainwright & Co. Assumes Karyopharm Therapeutics at Buy, Announces Price Target of $27

XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46361237/xpeng-opens-order-books-for-all-new-smart-coupe-suv-g6-and-smart-premium-suv-g9-in-europe" rel="noreferrer noopener">officially opened orders</a> in Europe on Friday for its fully revamped G6 Ultra Smart Coupe SUV and G9 Ultra Smart Premium SUV, marking its latest move towards AI-driven electric mobility. Both models feature next-generation 800V architecture, super-fast charging, and cutting-edge AI tech, tailored for European consumers.
XPeng built the new G6 and G9 on its full-domain 800V platform, enabling charging from 10% to 80% in just 12 minutes. The G6 peaks at 451 kW, and the G9 at 525 kW, offering WLTP ranges of 535 km and 585 km, respectively.
Both models are powered by the Qilin LFP battery, free of rare earth elements, and deliver strong efficiency, sustainability, and speed.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45903304/xpeng-says-its-new-self-driving-chip-is-3x-more-powerful-than-nvidias-will-power-vw-cars" rel="noreferrer noopener">Xpeng Says Its New Self-Driving Chip Is 3x More Powerful Than Nvidia&#8217;s, Will Power VW Cars</a>
XPeng equipped both models with a 4-3-4 safety structure and ballistic-grade battery protection, built to endure temperatures up to 1,000°C and 80 tons of pressure. The battery&#8217;s lifespan now extends 30% longer than before.
Both models integrate the Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) Snapdragon 8295 chipset and Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Orin-X processor, enabling features like automated parking, reverse tracking, and remote summon via smartphone or smart key. Voice control, immersive cockpits, and OTA updates enhance the smart driving experience.
XPeng will showcase the G6 at the Goodwood Festival of Speed (July 10-13, 2025). Orders are now open in France, Germany, Norway, Sweden, Denmark, the Netherlands, Belgium, and Luxembourg, with deliveries starting late summer 2025.
XPeng&#8217;s strong performance underscores its growth trajectory. The company&#8217;s stock has surged over 47% year-to-date. On May 21, the Chinese EV manufacturer reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45541540/chinas-xpeng-ev-deliveries-jump-330-ceo-cites-margin-improvement-for-7-consecutive-quarters" rel="noreferrer noopener">first-quarter 2025 sales growth</a>, with revenues increasing 141.5% year-on-year to 15.81 billion Chinese yuan ($2.18 billion). This topped the analyst consensus estimate of 16.02 billion Chinese yuan.
Quarterly vehicle deliveries also saw a significant jump of 330.8% year-over-year, reaching 94,008 units. Revenues from vehicle sales rose 159.2% year-over-year to 14.37 billion Chinese yuan ($1.98 billion) due to higher deliveries, and the gross margin improved to 15.6% from 12.9% a year ago, marking its seventh consecutive quarter of increase.
Looking ahead, XPeng projects second-quarter 2025 vehicle deliveries of 102,000-108,000 units, representing a year-over-year surge of 237.7%-257.5%. The company anticipates revenues between 17.5 billion Chinese yuan and 18.7 billion Chinese yuan, exceeding the analyst consensus estimate of 16.85 billion Chinese yuan.
Recent delivery figures further highlight XPeng&#8217;s accelerating momentum. On July 1, XPeng announced a 224% year-over-year increase in <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46189960/tesla-rival-xpeng-records-224-surge-in-june-deliveries-crosses-2024-sales-mark-in-6-months" rel="noreferrer noopener">June deliveries</a>, bringing its first-half 2025 deliveries to 197,189 units, surpassing the total units delivered in the entire year of 2024.
June marked the eighth consecutive month where XPeng delivered over 30,000 units, and the company also achieved a new quarterly record with 103,181 units delivered in the second quarter of 2025. The automaker said that it had expanded into over 40 countries and regions throughout the globe.
Price Action: XPEV shares are trading higher by 0.17% to $17.46 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46338887/whats-fueling-on-semiconductors-recent-stock-surge" target="_blank" rel="noreferrer noopener">What&#8217;s Fueling ON Semiconductor&#8217;s Recent Stock Surge?</a></li>
</ul>
Photo by Robert Way via Shutterstock

NVDA

QCOM

XPEV

XPeng Brings Ultra Smart, Ultra Fast EVs To Europe

VinFast Delivers 11,382 EVs In June, Topping 67,500 H1 Deliveries In Vietnam; VF 3 Leads Sales, New EV Plant Inaugurated In Ha Tinh

Keybanc analyst Steve Barger downgrades Federal Signal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSS#NYSE">FSS</a>) from Overweight to Sector Weight.

Downgrades

Keybanc Downgrades Federal Signal to Sector Weight

HIVE

HIVE Digital Hits 12 EH/s Hashrate, Achieves $250M Run Rate Revenue Amid Paraguay Hydro Expansion Toward 25 EH/s By Year-End

Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang will meet President Donald Trump at the White House on Thursday, one day before the chip designer&#8217;s head plans to visit China.
What Happened: The high-stakes meeting comes as Nvidia&#8217;s market capitalization <a href="https://www.benzinga.com/markets/tech/25/07/46349588/nvidia-hits-4-trillion-now-worth-more-than-meta-berkshire-hathaway-tesla-combined">closed above $4 trillion for the first time Thursday</a>, making it the world&#8217;s most valuable company and cementing its status as Wall Street&#8217;s most sought-after AI stock.
Details of the Trump-Huang discussions were not immediately available, Reuters reported, citing sources. 
The timing is critical as Huang has openly criticized export restrictions the Trump administration imposed in April that stopped Nvidia from selling its H20 chip <a href="https://www.benzinga.com/tech/25/05/45309175/nvidia-modifies-h20-chip-for-china-after-us-restrictions-block-sales-aims-to-deliver-new-version-by-july-report">designed for the Chinese market</a>. Huang previously called the restrictions &#8220;a springboard to global success&#8221; setback.
Nvidia and the White House did not immediately respond to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/news/politics/25/07/46362002/marco-rubio-holds-talks-with-chinas-wang-yi-at-east-asia-summit-amid-escalating-us-china-trade-tensions">Marco Rubio Holds Talks With China&#8217;s Wang Yi At East Asia Summit Amid Escalating US-China Trade Tensions</a>
Why It Matters: The export curbs cost the artificial intelligence <a href="https://www.benzinga.com/markets/equities/25/07/46268432/steve-jobs-knew-the-chip-was-the-queen-bee-kevin-oleary-says-us-must-let-nvidia-spread-its-hive-convince-every-bee-around-to-make-the-honey">chipmaker $2.5 billion in sales during the first quarter</a>, with Nvidia expecting an $8 billion revenue hit in the second quarter. The company has removed China from its revenue and profit forecasts following the stringent U.S. trade restrictions.
Nvidia&#8217;s $4 trillion valuation surpasses the <a href="https://www.benzinga.com/markets/tech/25/07/46349588/nvidia-hits-4-trillion-now-worth-more-than-meta-berkshire-hathaway-tesla-combined">combined market capitalization</a> of Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) at $1.82 trillion, Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) at $1.03 trillion and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) at $980 billion.
The meeting underscores the delicate balance between national security concerns and maintaining global market leadership in AI semiconductors. Recent intelligence reports suggest Chinese AI company DeepSeek has found <a href="https://www.benzinga.com/tech/25/05/45309175/nvidia-modifies-h20-chip-for-china-after-us-restrictions-block-sales-aims-to-deliver-new-version-by-july-report">workarounds to access large volumes of Nvidia&#8217;s H100 chips</a> despite export bans.
Read Next:
<ul class="wp-block-list">
<li><a href="https://benzinga.com/news/politics/25/07/46360686/trump-to-make-a-major-statement-on-russia-on-monday-amid-escalating-ukraine-conflict-im-disappointe?tblci=GiAShVRBa42nCBtWlx7IMC67Vo2BcWpr85L5I7snseW6sCCN1VcojO3Z1dW2jNkZMO-ISg" target="_blank" rel="noreferrer noopener">Trump To Make A ‘Major Statement' On Russia On Monday Amid Escalating Ukraine Conflict: ‘I'm Disappointed…'</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Nvidia CEO Jensen Huang To Meet Trump At White House Ahead Of Crucial China Visit: Report

MIST

Milestone Pharmaceuticals Launches Public Offering To Fund CARDAMYST Development, Includes Warrants And Pre-Funded Shares

Milestone Pharmaceuticals Secures FDA Review Acceptance For CARDAMYST, Extends $75M Royalty Deal With RTW Through 2025

<a target="_blank" href="https://www.benzinga.com/topic/cloud-computing" rel="noreferrer noopener">China&#8217;s cloud infrastructure spending</a> surged by 16% year-over-year to $11.6 billion in the first quarter of 2025, primarily fueled by the accelerating adoption of enterprise artificial intelligence (AI) nationwide.
This growth highlights cloud services&#8217; critical role in supporting China&#8217;s expanding AI capabilities, despite ongoing U.S. chip export restrictions.
The market is projected to continue its upward trajectory, with total cloud spending in China expected to climb from $40 billion in 2024 to $46 billion in 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46314590/alibaba-predicts-ai-digital-colleagues-will-be-commonplace-within-five-years" rel="noreferrer noopener">Alibaba Predicts AI Digital Colleagues Will Be Commonplace Within Five Years</a>
Alibaba Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) Cloud led the market with a 33% share and 15% revenue growth. Huawei Cloud followed it at 18% share and 18% growth, and Tencent (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCEHY#OTC">TCEHY</a>) Cloud at 10% share, which was reportedly limited by GPU supply issues, according to SCMP, <a target="_blank" href="https://www.scmp.com/tech/big-tech/article/3317760/chinas-cloud-services-spending-hits-us116-billion-first-quarter-ai-related-demand" rel="noreferrer noopener">citing</a> Canalys.
Partner-driven cloud revenue made up 25% of the market in the first quarter, with that share expected to grow as ecosystem collaboration turns AI capabilities into business value, according to Canalys.&nbsp;
Alibaba Cloud is experiencing rapid growth, particularly in its <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46250853/alibabas-ai-and-cloud-moves-have-sparked-28-stock-rebound" rel="noreferrer noopener">AI-driven products</a>, as its Qwen AI model family gains momentum.
Notably, Alibaba&#8217;s Damo Academy and Zhejiang Cancer Hospital jointly developed &#8220;Grape&#8221; in June, an AI model that detects early-stage gastric cancer from 3D CT scans, outperforming radiologists, as reported in Nature Medicine. This builds on Alibaba&#8217;s 2023 pancreatic cancer breakthrough, further integrating AI into healthcare.
The company is also expanding its global cloud footprint, launching new data centers in Malaysia, South Korea, and the Philippines. By 2025, Alibaba plans to roll out its Qwen models, Model Studio, and a global AI hub in Singapore, aiming to scale its cloud network across China, Asia, the Middle East, Europe, and the Americas over the next three years. 
This expansion is part of Alibaba&#8217;s &#8220;AI+Cloud&#8221; strategy, backed by a significant $53 billion investment plan to enhance cloud and AI infrastructure over the same period.
To deepen its AI expansion, Alibaba recently partnered with smartphone maker HONOR, marking the first direct integration of its AI agents into mobile devices. Unveiled during the HONOR Magic V5 launch on July 2, this collaboration brings Alibaba&#8217;s Qwen3 large language model (LLM) and Qwen-VL vision model to power HONOR&#8217;s YOYO assistant.
This enables advanced features like document analysis, role-play simulations, and real-time visual recognition, as Alizila <a target="_blank" href="https://www.alizila.com/alibaba-and-honor-deepen-ai-partnership-with-launch-of-new-smartphone/" rel="noreferrer noopener">reported</a> on Friday. Furthermore, specialized AI agents from Alibaba&#8217;s Fliggy and Amap now offer voice-enabled trip planning, navigation, and lifestyle recommendations within HONOR&#8217;s ecosystem.
Earlier in June, Alibaba <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46250853/alibabas-ai-and-cloud-moves-have-sparked-28-stock-rebound" rel="noreferrer noopener">launched updated</a> Qwen3 AI models to assist Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) in integrating machine-learning features into iPhones, iPads, and MacBooks in China. This supports Apple&#8217;s efforts to expand its &#8220;Apple Intelligence&#8221; offerings in the country while adhering to China&#8217;s AI regulations.
Preliminary Counterpoint Research data indicates that <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46246152/iphone-sales-bounce-back-in-china-but-huawei-and-xiaomi-intensify-pressure" rel="noreferrer noopener">China&#8217;s smartphone market</a> is poised for a rebound in the second quarter of 2025, with Huawei and Apple leading in year-over-year sales growth.
Huawei is expected to post the strongest growth among major brands, potentially claiming the top spot as loyal users upgrade to new models. Apple saw a sales boost in May, driven by iPhone 16 series discounts, especially on the Pro and Pro Max models.
Analysts attribute this second-quarter growth partly to government smartphone subsidies but caution about potential risks if these subsidies are reduced later in the year.
Alibaba stock has surged 26% year-to-date, fueled by AI-driven cloud growth, e-commerce strength, and the phasing out of non-core assets.
Price Action: BABA shares are trading higher by 0.29% to $106.96 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46342110/amazon-unveils-powerful-new-ai-servers-to-support-nvidias-most-advanced-chips" target="_blank" rel="noreferrer noopener">Amazon Unveils Powerful New AI Servers To Support Nvidia&#8217;s Most Advanced Chips</a></li>
</ul>
Photo via Shutterstock

Asia

Media

BABA

TCEHY

Alibaba, Huawei Dominate China's Growing Cloud Market

Needham analyst Mayank Tandon reiterates PAR Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAR#NYSE">PAR</a>) with a Buy and maintains $90 price target.

Needham Reiterates Buy on PAR Technology, Maintains $90 Price Target

Press Releases

Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering

Basel Medical Group Ltd Announces Exercise of Overallotment Option

Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move

Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities

Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement

Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility

The CHIPS Act and Peraso Inc. (NASDAQ: PRSO): Advancing Semiconductor Innovation and National Security – More Stocks Inside

Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising

BLRX

BMGL

BSLK

PRSO

SNYR

TIRX

VIVK

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

American Shared Hospital Services Common Stock

American Shared Hospital

Biodesix

Basel Medical Group

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Comments

Basel Medical Group

Basel Medical Group (BMGL) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO